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Objective: To investigate the relationship between angiotensin converting enzyme (ACE) gene insertion/deletion
(I/D) polymorphism and diabetic essential hypertension in elderly population.
Methods: Polymerase chain reaction (PCR) technique was used in 260 elderly normal control patients, 205 elderly
hypertensive patients and 138 elderly diabetic hypertensive patients to detect the I/D polymorphism in ACE gene.
Results: DD genotype frequency (0.352) and D allele frequency (0.543) in elderly hypertensive patients were higher
than those in the normal control patients. DD genotype (0.421) and D allele frequency (0.579) in elderly diabetic
hypertensive patients were significantly higher than those in the control patients (0.133 and 0.250). The differences
of DD genotype and D allele frequency between the elderly hypertensive patients and the elderly diabetic
hypertensive patients were not significant (P > 0.05).
Conclusion: ACE gene deletion is a risk factor for hypertension but is not a risk factor for diabetes in elderly population.
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hypertensionIntroduction
ACE is an important component of the renin - angioten-
sin system and plays an important role in hypertension
and other cardiovascular and cerebrovascular diseases [1].
Type 2 diabetes is a polygenic complex disease caused by
genetic factors and environmental factors [2], and the gen-
etic factors are quite essential in the development of type
2 diabetes [3]. Many studies showed that the genetic poly-
morphisms of some genes related to metabolism were
associated with type 2 diabetes [4], and the ACE gene
polymorphism was one of them. There is a 287 bp DNA
fragment insertion (insertion, I)/deletion (deletion, D) poly-
morphism in intron 16 of ACE gene [5], which was studied
in-depth in more and more basic researches [6-10]. And
the association between the ACE gene polymorphism and
the pathology of hypertension or diabetes has been paid* Correspondence: luohuilan998@163.com
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stated.more attention recently [7-9,11-15]. The present study
aimed to explore the association of ACE gene polymorph-
ism with hypertensive patients and with diabetic hyperten-
sion patients in elderly population in China.Subjects and methods
Subjects
260 subjects were enrolled in the elderly control group
(Male, n = 150, Female, n = 110), whose age were from
75 to 85 years (81.6 ± 4.55 years). They were admitted to
our hospital for medical examination and routine treat-
ment from the October 2006 to March 2013. They did
not have hypertension, diabetes, coronary heart disease
or any other cardiovascular disease.
205 patients were enrolled in elderly hypertensive group
(Male, n = 103, Female, n = 102), whose age were from 74
to 86 years (79.8 ± 6.28 years). Diagnosis of essential hyper-
tension was defined according to the WHO diagnostic cri-
teria of hypertension, namely as systolic blood pressure ≥
140 mmHg, diastolic blood pressure ≥ 90 mmHg.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 The genotyping results by 2.0% agarose.
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sion group (Male, n = 70, Female, n = 68, whose age were
from 75 to 83 years (79.12 ± 5.21 years). Diagnosis of dia-




The present study has been performed with the approval of
the ethics committee of General Hospital of the Air Force
PLA and is in compliance with the Helsinki Declaration.
Extraction of DNA template
The rapid DNA extraction kit (Jinan Xinbeixi Biotechnology
Co., Ltd. Jinan, China) was used for the extraction of the
template DNA according to the protocol of the Kit.
PCR amplification of the target fragment
Genotyping was conducted in accordance with kit in-
structions of the ACE gene I/D polymorphism assay
(Jinan Xinbeixi Biotechnology Co., Ltd., Jinan, China). The
primers sequences as follows: Upstream: 5’CCCAGGCCG
GGGACTCTGTA-3’; Downstream:5’AGCTCCAGCCCTT
AGCTCACCT3’. Genomic DNA, dNTPs and TaqDNA
polymerase were used for PCR mixture and each primer
were used for ACE. The PCR steps were as the following:
initial denaturation step at 94°C for 4 minutes, followed byTable 1 ACE genotype and allele frequencies in elderly contro
hypertensive and diabetic group
Groups n Genotypes
II
Control group 260 31 (11.9)
Hypertension group 205 61 (29.8)*#
Hypertension with diabetes group 138 44 (31.9)**
Note: Between the elderly hypertensive group and the control group: *χ2 for genot
hypertensive and diabetic group and the control group, **χ2 for genotypes = 10.62
group and the elderly hypertensive and diabetic group, #χ2 for genotypes =0.68, P>
Table 2 Lipids and glucose levels between each genotypes
Genotypes TG (mmol/L) TC (mmol/L) HD
II 1.4 ± 0.2 5.4 ± 1.1
ID 1.8 ± 0.4* 6.3 ± 1.7*
DD 1.9 ± 0.3** 6.5 ± 1.4**
Note: Compared to II genotype: *P < 0.05, **P < 0.01.36 cycles of denaturation at 94°C for 50 seconds, annealing
at 58°C for 30 seconds, extension at 72°C for 60 seconds
and a final extension at 72°C for 5 minutes. Amplified
products had two fragments: fragment with length of
490 bp was defined I allele, fragment with length of 190 bp
was defined D allele. II genotype had only 1 band of
490 bp, ID genotype had both 490 bp and 190 bp bands,
DD genotype had 1 band of 190 bp (Figure 1).
Statistical analysis
SPSS 13.0 software was utilized for the data analysis, The
genotype frequencies and the allele frequencies of ACE
gene among groups were compared using χ2 test, P <0.05
was considered significant difference.
Results
Hardy-Weinberg equilibrium test
ACE genotype distributions in three groups were in line
with Hardy-Weinberg equilibrium (all P > 0.05, data not
shown).
Genotype distribution
Compared to the healthy control group, the frequency of
ID and DD genotype was significantly higher in both
elderly hypertensive patients group and in elderly hyper-
tension with diabetes group (P <0.001). Similarly, the D
allele frequency was also higher in these two groups
comparing to the control group. We did not find signifi-
cant significance between elderly hypertensive group and
elderly hypertension with diabetes group in genotype or
allele frequency (Table 1).
Serum glucose and lipid levels in different genotypes
TG and LDL-C levels in patients with ID and DD
genotype were significantly higher than those in patientsl group, elderly hypertensive group and elderly
Allele
ID DD I D
60 (23.1) 169 (65.0) 23.5 76.5
78 (38.0)*# 66 (32.2)*# 48.8*# 51.2
51 (37.0)** 43 (31.1)** 0.50** 0.50
ypes = 20.09, P <0.001, χ2 for alleles = 23.63, P <0.001. Between the elderly
, P <0.001, χ2 for alleles = 22.4, P <0.001. Between the elderly hypertensive
0.05, χ2 for alleles = 0.29, P>0.05.
L-C (mmol/L) LDL-C (mmol/L) Glucose (mmol/L)
0.9 ± 0.3 2.4 ± 1.1 4.6 ± 0.8
1.2 ± 0.4* 3.1 ± 1.2* 5.7 ± 1.2*
1.3 ± 0.3** 3.3 ± 1.3** 6.4 ± 1.3**
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were not statistically significant in different genotypes
(P > 0.05), Table 2.
Discussion
Epidemiological studies show that the hypertension is a
polygenic disease, and the genetic and environmental fac-
tors were involved in the pathogenesis of hypertension to-
gether. ACE is the key enzyme in renin - angiotensin
system, which can catalyze the conversion of angiotensinI
to angiotensin II and is the ACE protein coding gene
[2,15]. ACE gene exists in chromosome 17q23 and con-
tains 26 exons and 25 introns with a total length of 21 kb.
Accordance with the presence or absence of 287 bp frag-
ment in intron 16, there is an insertion/deletion (I/D)
polymorphism. Some studies confirmed the presence of
three genotypes: deletion homozygous genotype DD, in-
sertion homozygous genotype II and heterozygous geno-
type ID.
Type 2 diabetes is a complex polygenic disease caused
by genetic factors and environmental factors, of which,
the genetic factors play the important role in the devel-
opment of type 2 diabetes [3]. In recent years, the rela-
tionship between ACE gene polymorphism and type 2
diabetes was inconsistent among different reports. For
example, in a recent published meta-analysis [16] report
showed that a total of 41 studies including 4708 cases
and 5368 controls were pool analyzed the association be-
tween ACE I/D polymorphism and T2DM in a Chinese
population. The authors found the pooled ORs for the
association between ACE I/D polymorphism and T2DM
risk were not statistically significant under all genetic
models (co-dominant model: DD vs. II: OR = 1.17, 95%
CI 0.97-1.42 and ID vs. II: OR = 1.01, 95% CI 0.93-1.10;
dominant model: OR = 1.06, 95% CI 0.94-1.19; multi-
plicative model: OR = 1.08, 95% CI 0.98-1.18). However,
Zarouk et al. [17] reported that the DD genotype and
the D allele are associated with hypertension and type 2
diabetes in Egyptian patients.
In the present study, we utilized the case - control
study to analyze the relationship between the ACE gene
polymorphism and elderly hypertension and diabetic
hypertension. The role of ACE gene in essential hyper-
tension remained controversial. Woo et al. [18] reported
ACE gene was not observed to be associated with essen-
tial hypertension. However, in another population-based
study, the D allele was found to be associated with hyper-
tension [19]. In addition, Kenric et al. also found that the
D allele was associated with hypertension in a group of
African Americans [20].
In this study, between elderly hypertensive group, elderly
hypertensive with diabetes group and healthy control
group, the frequencies of ID and DD genotype in ACE
gene, as well as the frequency of D allele, were significantlyincreased. Indicating that ACE gene deletion polymorph-
ism was associated with the pathogenesis of hypertension
in elderly. The present study also found that the ACE gene
I/D polymorphism was not a risk factor for type 2 diabetes
in the elderly population, which was consistent with some
reports [21-23]. In addition, this study also found that in
the different genotypes, TG and LDL-C levels in D allele
carriers significantly increased, but it had no effect on
blood glucose levels. The mechanism of ACE gene poly-
morphism affects the lipid levels was unclear, which is
worth further exploring.Conclusion
In summary, in Chinese elderly population, DD genotype
and D allele in ACE gene were associated with hyperten-
sion and lipid levels. However, they were not risk factors
for type 2 diabetes in Chinese elderly population.
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